Key result
TGF-beta signaling regulates endothelial-mesenchymal transition, contributing to the formation of cardiac fibroblasts and the development of cardiac fibrosis.
Answers are grounded in this paper and cite their sources.
Understanding the mechanisms of cardiac fibroblast formation via EndMT and TGF-β signaling may provide new therapeutic targets for heart diseases associated with fibrosis.
Most cardiac diseases caused by inflammation are associated with fibrosis in the heart. Fibrosis is characterized by the accumulation of fibroblasts and excess deposition of extracellular matrix (ECM), which results in the distorted organ architecture and function. Recent studies revealed that cardiac fibroblasts are heterogeneous with multiple origins. Endothelial-mesenchymal transition (EndMT) plays important roles in the formation of cardiac fibroblasts during pathological settings. EndMT is regulated by signaling pathways mediated by cytokines including transforming growth factor (TGF)-β. Better understanding of the mechanisms of the formation of cardiac fibroblasts via EndMT may provide an opportunity to develop therapeutic strategies to cure heart diseases.
No takes yet. Share an insight, caveat, or question.
Yoshimatsu et al. (2011) conducted a review in Cardiac fibrosis. TGF-beta signaling was evaluated. TGF-beta signaling regulates endothelial-mesenchymal transition, contributing to the formation of cardiac fibroblasts and the development of cardiac fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: